Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI) (RAPID STEMI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01452139
Recruitment Status : Completed
First Posted : October 14, 2011
Last Update Posted : April 25, 2013
Spartan Bioscience Inc.
Information provided by (Responsible Party):
Derek So, Ottawa Heart Institute Research Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2012
  Actual Study Completion Date : March 2013